BioNexus Gene Lab Corp (BGLC) income statement
BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$0.68+0.00 (0.00%)
Close on Nov 20, 2026Market cap $1.99MP/E –Yield –
BioNexus Gene Lab Corp financial ratios
See a number that looks wrong?